Alexander Burges Department of Obstetrics and Gynecology University Hospital, Ludwig-Maximilian-University (LMU) Munich Biography Publications Institution JoVE Articles Alexander Burges has not added a biography. If you are Alexander Burges and would like to personalize this page please email our Author Liaison for assistance. Publications Nuclear Receptor Co-repressor NCOR2 and Its Relation to GPER with Prognostic Impact in Ovarian Cancer Journal of Cancer Research and Clinical Oncology. Sep, 2023 | Pubmed ID: 37131060 PLA2G7/PAF-AH As Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer International Journal of Molecular Sciences. Jan, 2023 | Pubmed ID: 36614323 Risk of Postpartum Depressive Symptoms is Influenced by Psychological Burden Related to the COVID-19 Pandemic and Dependent of Individual Stress Coping Archives of Gynecology and Obstetrics. Dec, 2023 | Pubmed ID: 36482113 The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine Cells. Sep, 2021 | Pubmed ID: 34571986 Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer As a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway Biomedicines. Jun, 2021 | Pubmed ID: 34206491 Nuclear Enolase-1/ MBP-1 Expression and Its Association with the Wnt Signaling in Epithelial Ovarian Cancer Translational Oncology. Jan, 2021 | Pubmed ID: 33069100 β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation Frontiers in Endocrinology. 2020 | Pubmed ID: 33042017 Cytoplasmic VDR Expression As an Independent Risk Factor for Ovarian Cancer Histochemistry and Cell Biology. Oct, 2020 | Pubmed ID: 32572587 M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis Cells. May, 2020 | Pubmed ID: 32429133 Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients International Journal of Molecular Sciences. Jun, 2019 | Pubmed ID: 31212758 Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients International Journal of Molecular Sciences. Dec, 2018 | Pubmed ID: 30597961 Ovarian Cancer: Diagnosis and Treatment Deutsches Arzteblatt International. Sep, 2011 | Pubmed ID: 22025930 Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM X Anti-CD3 Antibody: a Phase I/II Study Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jul, 2007 | Pubmed ID: 17606723 Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 癌症研究
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer Fabian Trillsch*1,2, Juliane Reichenbach*1, Bastian Czogalla1, Fabian Kraus1, Alexander Burges1, Sven Mahner1,2, Mirjana Kessler1,2 1Department of Obstetrics and Gynecology, University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich JoVE 66467 癌症研究
